(Q35587186)

9 August 2017

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

0 references

1 reference

Abdullah Alfawaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

Sultan Alrashidi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

Hatem Kalantan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

Hani Al-Mezaine

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

Ahmed M Abu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

publication date

1 July 2014

1 reference

9 August 2017

Annals of Saudi Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

page(s)

328-333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

12 May 2020

cites work

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Novel approaches to Behçet's disease

1 reference

12 December 2020

Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy

1 reference

12 December 2020

CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

1 reference

12 December 2020

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

1 reference

12 December 2020

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

12 December 2020

Male sex, erythema nodosum, and electroretinography as predictors of visual prognosis after cataract surgery in patients with Behçet disease.

1 reference

12 December 2020

Intraocular surgery in patients receiving infliximab therapy for Behçet disease

1 reference

12 December 2020

Cytokine production profile in patients with Behcet's disease treated with infliximab

1 reference

12 December 2020

Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up

1 reference

12 December 2020

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

1 reference

12 December 2020

Clinical features of chinese patients with Behçet's disease

1 reference

12 December 2020

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease

1 reference

12 December 2020

The results of cataract extraction and intraocular lens implantation in patients with Behçet's disease

1 reference

12 December 2020

The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement

1 reference

12 December 2020

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

12 December 2020

Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.

1 reference

12 December 2020

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

1 reference

12 December 2020

Cataract extraction in uveitis patients

1 reference

12 December 2020

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease

1 reference

12 December 2020

Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

1 reference

12 December 2020

Patterns of uveitis in patients admitted to a University Hospital in Riyadh, Saudi Arabia

1 reference

12 December 2020

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

12 December 2020

Cataract extraction in Behçet's disease

1 reference

12 December 2020

Prognosis in Behcet's disease

1 reference

12 December 2020

Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease.

1 reference

12 December 2020

Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease

1 reference

12 December 2020

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

1 reference

12 December 2020

Long-term efficacy and safety of infliximab in the treatment of Behçet's disease

1 reference

12 December 2020

Cataract surgery under infliximab therapy in a patient with Behçet's disease

1 reference

12 December 2020

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease

1 reference

12 December 2020

Cataract surgery in patients with Behçet's disease

1 reference

12 December 2020

Induction of regulatory T cells by infliximab in Behcet's disease

1 reference

12 December 2020

10.5144/0256-4947.2014.328

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6152558&resulttype=core&format=json

12 May 2020

1 reference